Table of Contents page: Digestive and Liver Disease

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Editorial Board

Published in issue: November 2020

i-ii

Children and Fecal SARS-CoV-2 shedding: Just the tip of the Iceberg of Italian COVID-19 outbreak?

Salvatore Oliva,
Salvatore Cucchiara,
Franco Locatelli

Published online: July 18, 2020

p1219-1221

COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data

Fabio Salvatore Macaluso,
Ambrogio Orlando

Published online: September 06, 2020

p1222-1227

Onset of ulcerative colitis during SARS-CoV-2 infection

Emma Calabrese,
Francesca Zorzi,
Giovanni Monteleone,
Giovanna Del Vecchio Blanco

Published online: June 11, 2020

p1228-1229

Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak.

Cherradi Younes

Published online: May 29, 2020

p1230

COVID-19 and intestinal inflammation: Role of fecal calprotectin

Veronica Ojetti,
Angela Saviano,
Marcello Covino,
...
Eliana Troiani,
Francesco Franceschi
GEMELLI AGAINST COVID‐19 group

Published online: September 22, 2020

p1231-1233

Low frequency of COVID-19 in inflammatory bowel diseases

Irene Marafini,
Silvia Salvatori,
Giorgia Sena,
Emma Calabrese,
Livia Biancone,
Giovanni Monteleone

Published online: June 13, 2020

p1234-1235

Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era

Olga Maria Nardone,
Antonio Rispo,
Fabiana Castiglione

Published online: July 19, 2020

p1236-1237

The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When “non-urgent” does not mean “deferrable”

Daniela Pugliese,
Claudio Papi,
Giuseppe Privitera,
Annalisa Aratari,
Stefano Festa,
Alessandro Armuzzi

Published online: June 18, 2020

p1238-1240

Urgent surgery for inflammatory bowel diseases during the COVID-19 outbreak in a high incidence area - Experience from a high-volume centre

Fiorenzo Botti,
Stefano Mazza,
Stefano Costa,
Elisa Farina,
Ludovica Baldari,
Matteo Prati

Published online: August 31, 2020

p1241-1243

SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy?

Giulia Bardasi,
Patrizia Alvisi

Published online: July 11, 2020

p1244-1245

Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns

Stefano Festa,
Annalisa Aratari,
Fabiola De Biasio,
Federica Fascì-Spurio,
Claudio Papi

Published online: May 25, 2020

p1246-1247

Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre

Fabiana Zingone,
Andrea Buda,
Edoardo Savarino

Published online: July 27, 2020

p1248-1249

Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.

Ralley E. Prentice,
Aysha H Al-Ani,
Katherine Bond,
Doug Johnson,
Britt Christensen

Published online: August 27, 2020

p1250-1251

Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice

Fabiana Zingone,
Andrea Buda,
Edoardo Savarino

Published online: September 26, 2020

p1252-1253

Systematic review on failure to adhere to IBD therapies during the COVID-19 pandemic: Correct information is crucial

Anuraag Jena,
Anupam Kumar Singh,
Praveen Kumar-M,
Vishal Sharma,
Shaji Sebastian

Published online: September 19, 2020

p1254-1256

Safe administration of corticosteroids in severe ulcerative colitis and active SARS-CoV2 infection

Pierre Mayer,
Antonio Saviano,
Loïc Kassegne,
Thomas F. Baumert,
Jean-Marie Reimund,
François Habersetzer

Published online: July 27, 2020

p1257-1258

Review Article

Enhancing treatment success in inflammatory bowel disease: Optimising the use of anti-TNF agents and utilising their biosimilars in clinical practice

Alessandro Armuzzi,
Yoram Bouhnik,
Fraser Cummings,
Marion Bettey,
Burkhard Pieper,
Taegyun Kang

Published online: June 26, 2020

p1259-1265

Open Access

Foreign body and caustic ingestions in children: A clinical practice guideline

Salvatore Oliva,
Claudio Romano,
Paola De Angelis,
...
Massimo Martinelli,
Lorenzo Norsa
on behalf of the Italian Society of Pediatric Gastroenterology Hepatology and Nutrition (SIGENP), and The Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO)

Published online: August 08, 2020

p1266-1281

Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging

Cholangiocarcinoma Working Group

Published online: September 03, 2020

p1282-1293

Endoscopic ultrasound-guided gastro-enteric anastomosis: A systematic review and meta-analysis

Giulio Antonelli,
Bojan Kovacevic,
John Gásdal Karstensen,
...
Giuseppe Vanella,
Cesare Hassan,
Peter Vilmann

Published online: June 03, 2020

p1294-1301

Comment to “Biosimilars: The viewpoint of Italian patients with inflammatory bowel disease”

Manuel Barreiro de Acosta,
Konstantinos H. Katsanos

Published online: September 08, 2020

p1302-1303

Biosimilars: The viewpoint of Italian patients with inflammatory bowel disease

Fabio Salvatore Macaluso,
Salvatore Leone,
Enrica Previtali,
...
Alessandro Armuzzi,
Ambrogio Orlando
on behalf of AMICI (Italian Inflammatory Bowel Disease Patients' Association) and IG-IBD (Italian Group for the Study of Inflammatory Bowel Disease)

Published online: August 14, 2020

p1304-1309